1. Machine Learning Based Radiomics for Glial Tumor Classification and Comparison with Volumetric Analysis
- Author
-
Turk, Sevcan, Oguz, Kaya, Orman, Mehmet, Caliskan, Emre, Ertan, Yesim, Ozgiray, Erkin, Akalin, Taner, Srinivasan, Ashok, and Kitis, Omer
- Subjects
Electrical Engineering and Systems Science - Image and Video Processing ,Computer Science - Computer Vision and Pattern Recognition ,Computer Science - Machine Learning ,Physics - Medical Physics - Abstract
Purpose; The purpose of this study is to classify glial tumors into grade II, III and IV categories noninvasively by application of machine learning to multi-modal MRI features in comparison with volumetric analysis. Methods; We retrospectively studied 57 glioma patients with pre and postcontrast T1 weighted, T2 weighted, FLAIR images, and ADC maps acquired on a 3T MRI. The tumors were segmented into enhancing and nonenhancing portions, tumor necrosis, cyst and edema using semiautomated segmentation of ITK-SNAP open source tool. We measured total tumor volume, enhancing-nonenhancing tumor, edema, necrosis volume and the ratios to the total tumor volume. Training of a support vector machine (SVM) classifier and artificial neural network (ANN) was performed with labeled data designed to answer the question of interest. Specificity, sensitivity, and AUC of the predictions were computed by means of ROC analysis. Differences in continuous measures between groups were assessed by using Kruskall Wallis, with post hoc Dunn correction for multiple comparisons. Results; When we compared the volume ratios between groups, there was statistically significant difference between grade IV and grade II-III glial tumors. Edema and tumor necrosis volume ratios for grade IV glial tumors were higher than that of grade II and III. Volumetric ratio analysis could not distinguish grade II and III tumors successfully. However, SVM and ANN correctly classified each group with accuracies up to 98% and 96%. Conclusion; Application of machine learning methods to MRI features can be used to classify brain tumors noninvasively and more readily in clinical settings.
- Published
- 2022